Copyright
©The Author(s) 2023.
World J Gastroenterol. Feb 28, 2023; 29(8): 1374-1394
Published online Feb 28, 2023. doi: 10.3748/wjg.v29.i8.1374
Published online Feb 28, 2023. doi: 10.3748/wjg.v29.i8.1374
Table 3 Characteristics of various covariates and their association with outcome measures
Ref. | PERT use, n (%) | Inflammatory markers: CRP/IL-6, mean ± SD | Vitamin D deficiency, n (%) | Serum PTH, mean ± SD | Alcohol exposure, n (%) | Smokers, n (%) | Diabetes, n (%) | Nutritional parameters | Relevant covariates findings |
Morán et al[17], 1997 | CP: 4 (28.57) | CP: - | CP: 7 (50) | CP: - | CP: 0 | CP: - | CP: - | Mean serum albumin 3.8 g/dL, 4 (28.6) had BMI < 20. Non-significant associations between osteopathy and BMI | Non-significant associations between osteopathy and (1) CP severity (as per fecal fat or bicarbonate secretion assessments); (2) CP etiology; (3) Age; and (4) Vitamin D, PTH or calcium |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Haaber et al[18], 2000 | CP: 26 (44.82) | CP: - | CP: - | CP: 401 (31) | CP: - | CP: - | CP: - | Non-significant associations between osteopathy and (1) Duration of CP; and (2) Vitamin D and PTH | |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Dujsikova et al[19], 2008 | CP: - | CP: - | CP: 63 (86.3) | CP: - | CP: 8 (10.95) | CP: - | CP: - | Non-significant associations between osteopathy and severity of disease | |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Tignor et al[20], 2010 | CP: - | CP: - | CP: - | CP: - | CP: - | CP: - | CP: - | No descriptions of regression analysis or covariate adjustment | |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Sudeep et al[22], 2011 | CP: - | CP: - | CP: 16 (51.6) | CP: - | CP: - | CP: - | CP: - | BMI correlated significantly with BMC (r = 0.426; P = 0.017). There was an inverse correlation between stool fat and BMC (r = -0.47; P = 0.03) | Non-significant associations between osteopathy and (1) EPI (as per 72-hour fecal fat); and (2) Vitamin D |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Joshi et al[21], 2011 | CP: 33 (45.83) | CP: CRP < 0.32 (-) | CP: 62 (86.11) | CP: 43.381 (-) | CP: - | CP: 7 (9.7) | CP: 52 (72.2) | Lumbar Z score was associated with BMI (beta: 0.276; P = 0.04), serum albumin was significantly lower in patients compared with controls [4.0 (0.6) vs 4.6 (0.7) g/dL, P < 0.001] | |
Controls: - | Controls: CRP < 0.32 (-) | Controls: 85 (85) | Controls: 84.871 (-) | Controls: - | Controls: - | Controls: - | |||
Significant association of Lumbar Z score with log vitamin D (beta: 0.274; P = 0.04) | |||||||||
Duggan et al[23], 2012 | CP: - | CP: - | CP: - | CP: - | CP: 58 (93.5) | CP: 46 (74.19) | CP: - | BMI < 20: low BMD: 15 (23.8) vs normal BMD 10 (1.1) | Higher T scores for the lowest age tertile (P = 0.003). Lower T-score for smokers (P = 0.002). Non-significant associations between T scores at any area and (1) CP severity; (2) EPI; and (3) Ssex |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: 62 (93.9) | Controls: 40 (60.6) | Controls: - | |||
Sikkens et al[25], 2013 | CP: 19 (47.5) | CP: - | CP: - | CP: - | CP: 1 (2.5) | CP: 27 (67.5) | CP: - | A high BMI is predictive of a ‘‘higher’’ lowest T-score [Coeff: 0.58 (0.2); P = 0.003] | Significant association between osteopathy and untreated EPI (P = 0.013) |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Prabhakaran et al[28], 2014 | CP: - | CP: - | CP: 20 (19.41) | CP: 27.6 (39.8) | CP: 72 (69.9) | CP: - | CP: 39 (37.86) | - | Non-significant associations between osteopathy and (1) EPI (as per steatorrhea assessment); (2) CP severity; and (3) CP etiology |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Non-significant associations between osteopathy and vitamin D, PTH and alkaline phosphatase | |||||||||
Bang et al[26], 2014 | CP: 3545 (29.61) | CP: - | CP: - | CP: - | CP: 3651 (30.49) | CP: - | CP: - | Increased risk of fracture among smokers (HR, 1.8; 95%CI, 1.7-1.8) and alcohol related CP (HR, 2.0 vs 1.5; P < 0.0001) | |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: 2753 (2.29) | Controls: - | Controls: - | |||
Reduced fracture risk among PERT treated CP patients (HR, 0.8; 95%CI, 0.7-0.9) | |||||||||
Duggan et al[27], 2015 | CP: - | CP: CRP: 3.15 (-), IL-6: 5.61 (-) | CP: 20 | CP: 47.1 (19.4) | CP: 27 (93.10) | CP: 23 (79.3) | CP: - | Lower T scores were associated with BMI (P = 0.04) | Lower T scores were associated with age (P = 0.006). Non-significant association with carboxy-terminal telopeptide of type I collagen; osteocalcin; Procollagen 1 amino-terminal propeptide |
Controls: - | Controls: CRP: 0.9 (-), IL-6: 3.58 (1.82) | Controls: 18 | Controls: 46.3 (14) | Controls: 28 (96.55) | Controls: 10 (34.4) | Controls: - | |||
Non-significant association with IL-6 and CRP | Lower T scores were associated with serum vitamin D (P = 0.002). No association with PTH | ||||||||
Munigala et al[24], 2016 | CP: - | CP: - | CP: - | CP: - | CP: 494 (15.16) | CP: 505 (15.5) | CP: - | A significant association of BMD in the columnar spine with vitamin D level (coefficient 0.13 g/cm2; P = 0.017) and BMI (coefficient 0.14 g/cm2; P = 0.007) were observed on univariate analysis | Increased fracture risk among males (adjusted OR, 1.73% (95%CI: 1.46%-2.05%); P < 0.0001), alcohol consumers (OR, 2.30), and smokers (OR, 1.97). Non-significant associations between osteopathy and age |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: 37146 (8.24) | Controls: 77926 (17.29) | Controls: - | |||
Kumar et al[29], 2017 | CP: - | CP: - | CP: 69 (67.64) | CP: - | CP: - | CP: - | CP: 54 (52.94) | A MUST score (malnutrition score) of 1 or higher was associated with an increased risk for osteopenia and osteoporosis on Fisher’s exact test (P = 0.0037) | Non-significant association between osteopathy and duration of CP |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Non-significant association between osteopathy and vitamin D | |||||||||
Stigliano et al[32], 2018 | CP: 116 (54.97) | CP: - | CP: 119 (56.39) | CP: - | CP: 127 (60.18) | CP: 145 (68.72) | CP: 77 (36.49) | Observed significant association of BMI with osteopathy (OR 0.89; 95%CI: 0.83-0.96; P = 0.003) | Osteopathy more prevalent with increasing age (OR 1.06; P = 0.0002), female sex (OR: 3.44; P = 0.0005). Non-significant association between osteopathy and (1) CP severity; (2) EPI (as assessed by fecal elastase); (3) Smoking; (4) Duration of CP; and (5) Alcohol exposure |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Non-significant association between osteopathy and PERT usage | Non-significant association between osteopathy and IL-6/CRP | Non-significant association between osteopathy, vitamin D and PTH | |||||||
Kuhlmann et al[30], 2018 | CP: 28 (41.79) | CP: - | CP: - | CP: - | CP: 42 (62.68) | CP: 42 (62.68) | CP: 22 (32.83) | The underweight BMI category, had significant higher odds of osteopathy (OR: 7.40; 95%CI: 1.56-34.99; P < 0.001) | Lower Z scores associated with (1) EPI (P = 0.01); (2) Smoking (P = 0.02). Non-significant association with alcohol exposure |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Lower Z scores associated with vitamin D (P = < 0.001) | |||||||||
Min et al[31], 2018 | CP: - | CP: - | CP: - | CP: - | CP: - | CP: - | CP: - | Non-significant association with BMI | Non-significant association with (1) CP severity; (2) PERT usage |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Gupta et al[33], 2019 | CP: - | CP: - | CP: - | CP: - | CP: 13 (34.21) | CP: 18 (47.36) | CP: 12 (31.57) | Low bone mass was associated with lower BMI. Non-significant association with CP duration | |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Kanakis et al[7], 2020 | CP: - | CP: - | CP: - | CP: - | CP: 130 (54.39) | CP: 132 (55.23) | CP: - | For patients, there was no association between total hip BMD and BMI (P = 0.753) | No descriptions of regression analysis or covariate adjustment |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Hart et al[34], 2021 | CP: 161 (57.09) | CP: - | CP: - | CP: - | CP: - | CP: 191 (67.7) | CP: 111 (39.36) | Higher osteopathy risk associated with low BMI (P ≤ 0.001) | Increased risk of osteopathy with white race (P = 0.017), age (P ≤ 0.001), female sex (P ≤ 0.01) and past or present smoking (P ≤ 0.01). No associations with (1) CP severity (per atrophy assessment); and (2) Duration of CP |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Reduced osteopathy among PERT users (P = 0.02) | |||||||||
Vujasinovic et al[8], 2021 | CP: 104 (88.13) | CP: - | CP: - | CP: - | CP: 53 (44.91) | CP: 76 (64.4) | CP: 28 (23.72) | ||
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Reduced time to first fracture in PERT-treated patients | |||||||||
Tang et al[35], 2021 | CP: 51 | CP: CRP: 0.75 (-), IL-6: 4.51 (-) | CP: 76 (73.07) | CP: 40.86 | CP: 52 (50) | CP: 45 (43.26) | CP: 28 (26.92) | Independent predictors of osteopathy: BMI (OR, 0.72; 95%CI, 0.58-0.89; P = 0.003) | Non-significant association between osteopathy and (1) Age; and (2) Duration of CP |
Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | Controls: - | |||
Non-significant association between osteopathy and IL-6/CRP | Non-significant association between osteopathy and PTH |
- Citation: Chhoda A, Hernandez-Woodbine MJ, Addo NAA, Nasir SA, Grimshaw A, Gunderson C, Ahmed A, Freedman SD, Sheth SG. Burden of bone disease in chronic pancreatitis: A systematic review and meta-analysis. World J Gastroenterol 2023; 29(8): 1374-1394
- URL: https://www.wjgnet.com/1007-9327/full/v29/i8/1374.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i8.1374